Target intelligence / Profile preview

Large ribosomal subunit 50S (50S)

Target
50S
Molecular classification
Ribosome, Ribosomal subunit, Ribonucleoprotein complex, Other
01

Overview

The **large ribosomal subunit 50S** is the bigger component of the 70S ribosome in prokaryotes (bacteria and archaea), composed primarily of 23S and 5S ribosomal RNAs and more than 30 associated proteins[1][4]. It is responsible for catalyzing peptide bond formation during protein synthesis and facilitates interactions with tRNAs as well as numerous factors that regulate translation[1][4][2]. The 50S subunit is a crucial target for several classes of antibiotics, which inhibit bacterial protein synthesis by binding to specific sites on the subunit and interfering with its catalytic or structural functions[1][6]. Mutations or modifications in the 50S subunit, especially in the 23S rRNA, are key mechanisms underlying antibiotic resistance in bacteria. The subunit is essential for cell viability and has no direct equivalent in eukaryotes, where the analogous subunit is the 60S.

Other names
50S large ribosomal subunitprokaryotic 50S ribosomal subunit50S subunit
02

Mechanism of action

Inhibition of protein synthesis by binding to 50S and blocking peptide bond formation or translocation Inhibition of peptidyl transferase activity Prevention of ribosomal subunit association

03

Biological functions

Protein synthesisPeptide bond formation (peptidyl transferase activity)Binding site for G-proteins (initiation, elongation, termination factors)Structural role in ribosome assemblyMediation of tRNA positioning during translation
04

Disease associations

Infection (bacterial)Other (potential for indirect involvement in antimicrobial resistance)
05

Safety considerations

Off-target effects on mitochondrial ribosomes in humans (mitochondrial toxicity; rare, for some antibiotics such as chloramphenicol)Development of antibiotic resistance (e.g., mutations, methylation)Hypersensitivity reactions to drugsNull
06

Interacting drugs

Macrolide antibiotics (e.g., azithromycin, clarithromycin, erythromycin)

3 more in the full profile.

07

Biomarkers

Mutations in 23S rRNA (e.g., conferring resistance to macrolides or chloramphenicol)Presence of methylases that modify ribosome targets (e.g., erm genes in bacteria)null

Beyond the preview

Go deeper on Large ribosomal subunit 50S (50S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large ribosomal subunit 50S (50S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call